{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:11:54Z","timestamp":1793664714427,"version":"4.5.1"},"update-to":[{"DOI":"10.1002\/14651858.cd009566","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000}}],"reference-count":68,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009566.pub2","type":"journal-article","created":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T02:34:27Z","timestamp":1433126067000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis"],"prefix":"10.1002","volume":"2015","author":[{"given":"Mayret","family":"Castillo","sequence":"first","affiliation":[{"name":"Queen's University Belfast; Belfast UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil W","family":"Scott","sequence":"additional","affiliation":[{"name":"University of Aberdeen; Medical Statistics Team; Polwarth Building Foresterhill Aberdeen Scotland UK AB 25 2 ZD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Z","family":"Mustafa","sequence":"additional","affiliation":[{"name":"Princess Alexandra Eye Pavilion; Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S","family":"Mustafa","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital Dubai; P.O. Box 505054, Dubai Healthcare City Al Razi Building, Block E, 3rd Floor Dubai United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Azuara-Blanco","sequence":"additional","affiliation":[{"name":"Queen's University Belfast; Centre for Experimental Medicine; Grosvenor Road Belfast UK BT12 6BA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,6,1]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD009566.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.clinthera.2005.09.013","article-title":"Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial","volume":"27","author":"Avunduk","year":"2005","journal-title":"Clinical Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD009566.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2222.1991.tb03197.x","article-title":"Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in treatment of seasonal conjunctivitis","volume":"21","author":"Azevedo","year":"1991","journal-title":"Clinical and Experimental Allergy"},{"issue":"4","key":"10.1002\/14651858.CD009566.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1185\/030079903125001794","article-title":"Topical azelastine in perennial allergic conjunctivitis","volume":"19","author":"Canonica","year":"2003","journal-title":"Current Medical Research & Opinion"},{"issue":"3","key":"10.1002\/14651858.CD009566.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2500\/aap.2013.34.3671","article-title":"Efficacy of Bepotastine besilate ophthalmic solution 1.5% for seasonal allergic conjunctivitis: A randomized, placebo-controlled, natural exposure, clinical trial","volume":"34","author":"Carr","year":"2013","journal-title":"Allergy Asthma Proceedings"},{"issue":"7","key":"10.1002\/14651858.CD009566.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1398-9995.1993.tb01108.x","article-title":"Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis","volume":"48","author":"Davies","year":"1993","journal-title":"Allergy"},{"issue":"4","key":"10.1002\/14651858.CD009566.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000130072","article-title":"The effect of a combined therapy with a histamine H1 antagonist and a chemical mediator release inhibitor on allergic conjunctivitis","volume":"222","author":"Fujishima","year":"2008","journal-title":"Ophthalmologica"},{"issue":"9","key":"10.1002\/14651858.CD009566.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1398-9995.1998.tb03991.x","article-title":"Azelastine eye-drops in seasonal allergic conjunctivitis or rhinoconjunctivitis. A double-blind, randomized, placebo-controlled study","volume":"53","author":"Giede-Tuch","year":"1998","journal-title":"Allergy"},{"issue":"1","key":"10.1002\/14651858.CD009566.pub2-BIB0008|cit8","first-page":"35","article-title":"Double-masked study of topical levocabastine versus topical placebo in management of seasonal conjunctivitis","volume":"21","author":"Graue","year":"1994","journal-title":"Investigacion Medica Internacional"},{"issue":"2","key":"10.1002\/14651858.CD009566.pub2-BIB0009|cit9","first-page":"59","article-title":"A double-blind study comparing sodium cromoglycate eye ointment with placebo in the treatment of chronic allergic conjunctivitis","volume":"21","author":"Hechanova","year":"1984","journal-title":"Clinical Trials Journal"},{"issue":"5","key":"10.1002\/14651858.CD009566.pub2-BIB0010|cit10","first-page":"415","article-title":"Comparison between topical use of ketotifen and olopatadine in the treatment of allergic conjunctivitis","volume":"64","author":"H\u00f6ffling-Lima","year":"2001","journal-title":"Arquivos Brasileiros de Oftalmologia"},{"issue":"4","key":"10.1002\/14651858.CD009566.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1185\/030079903125001785","article-title":"Comparison of the efficacy and tolerability of topically administered azelastine, sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis and rhinoconjuctivitis","volume":"19","author":"James","year":"2003","journal-title":"Current Medical Research and Opinion"},{"issue":"10","key":"10.1002\/14651858.CD009566.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0149-2918(02)80060-1","article-title":"A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis","volume":"24","author":"Katelaris","year":"2002","journal-title":"Clinical Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD009566.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/bjo.87.10.1206","article-title":"Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis","volume":"87","author":"Kidd","year":"2003","journal-title":"British Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD009566.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1081-1206(10)62292-2","article-title":"Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms","volume":"86","author":"Lanier","year":"2001","journal-title":"Annals of Allergy, Asthma and Immunology"},{"issue":"10","key":"10.1002\/14651858.CD009566.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-2222.1992.tb02066.x","article-title":"Double-blind group comparative study of 2% nedocromil sodium eye drops with 2% sodium cromoglycate and placebo eye drops in the treatment of seasonal allergic conjunctivitis","volume":"22","author":"Leino","year":"1992","journal-title":"Clinical and Experimental Allergy"},{"issue":"1","key":"10.1002\/14651858.CD009566.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1185\/03007999709113339","article-title":"Double-blind, randomised, placebo-controlled study of two concentrations of azelastine eye drops in seasonal allergic conjunctivitis or rhinoconjunctivitis","volume":"14","author":"Lenhard","year":"1997","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD009566.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2147\/OPTH.S35431","article-title":"Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.2% ophthalmic solution evaluated by patient preference","volume":"6","author":"McCabe","year":"2012","journal-title":"Clinical Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD009566.pub2-BIB0018|cit18","first-page":"57","article-title":"Evaluation of nedocromil sodium 2% ophthalmic solution for the treatment of seasonal allergic conjunctivitis","volume":"73","author":"Melamed","year":"1994","journal-title":"Annals of Allergy"},{"issue":"4","key":"10.1002\/14651858.CD009566.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2500\/108854100778248863","article-title":"Efficacy and safety of nedocromil sodium 2% ophthalmic solution b.i.d. in the treatment of ragweed seasonal allergic conjunctivitis","volume":"21","author":"Melamed","year":"2000","journal-title":"Allergy and Asthma Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD009566.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1365-2222.1994.tb01811.x","article-title":"Nedocromil sodium 2% eye drops for twice-daily treatment of seasonal allergic conjunctivitis: a Swedish multicentre placebo-controlled study in children allergic to birch pollen","volume":"24","author":"M\u00f6ller","year":"1994","journal-title":"Clinical and Experimental Allergy"},{"issue":"3","key":"10.1002\/14651858.CD009566.pub2-BIB0021|cit21","first-page":"167","article-title":"Azelastine eye drops in the treatment of perennial allergic conjunctivitis","volume":"53","author":"Nazarov","year":"2003","journal-title":"Arzneimittel-Forschung"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009566.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0091-6749(02)81613-X","article-title":"Efficacy and safety of azelastine in allergic conjunctivitis in children","volume":"109","author":"Petzold","year":"2002","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1002\/14651858.CD009566.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1185\/03007999809113356","article-title":"Azelastine eye drops in the treatment of seasonal allergic conjunctivitis or rhinoconjunctivitis in young children","volume":"14","author":"Sabbah","year":"1998","journal-title":"Current Medical Research and Opinion"},{"issue":"5","key":"10.1002\/14651858.CD009566.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2217\/thy.11.48","article-title":"Comparison of the therapeutic efficacy of 0.1% olopatadine hydrochloride and 0.025% ketotifen fumarate in allergic conjunctivitis","volume":"8","author":"Sarker","year":"2011","journal-title":"Therapy"},{"key":"10.1002\/14651858.CD009566.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1034\/j.1600-0420.2000.078s230042.x","article-title":"Safety and efficacy comparison of emedastine 0.05% ophthalmic solution compared to levocabastine 0.05% ophthalmic suspension in pediatric subjects with allergic conjunctivitis","volume":"78","author":"Secchi","year":"2000","journal-title":"Acta Ophthalmologica Scandinavica. Supplement"},{"key":"10.1002\/14651858.CD009566.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1034\/j.1600-0420.2000.078s230048.x","article-title":"An efficacy and tolerance comparison of emedastine difumarate 0.05% and levocabastine hydrochloride 0.05%: reducing chemosis and eyelid swelling in subjects with seasonal allergic conjunctivitis","volume":"78","author":"Secchi","year":"2000","journal-title":"Acta Ophthalmologica Scandinavica. Supplement"},{"key":"10.1002\/14651858.CD009566.pub2-BIB0027|cit27","unstructured":"Trinquand C Belayachi N Hoang-Xuan T International Mequitazine Investigators Group Clinical double masked comparison of Mequitazine eyedrops 0.05% compared to Levocabastine eyedrops 0.05% in allergic conjunctivitis Investigative Ophthalmology and Visual Science 1999 ARVO E-Abstract 4819"},{"issue":"4","key":"10.1002\/14651858.CD009566.pub2-BIB0028|cit28","first-page":"399","article-title":"Olopatadine and ketotifen for the treatment of allergic conjunctivitis","volume":"47","author":"Varguez-Rodriguez","year":"2009","journal-title":"Revista M\u00e9dica del Instituto Mexicano del Seguro Social"},{"issue":"6","key":"10.1002\/14651858.CD009566.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0002-9394(00)00947-8","article-title":"Clinical evaluation of twice-daily emedastine 0.05% eye drops (emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis","volume":"131","author":"Verin","year":"2001","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD009566.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2008-1035023","article-title":"Antazolin\/tetryzolin-eyedrops in comparison to levocabastine-eyedrops in acute allergic conjunctivitis","volume":"210","author":"Wertheimer","year":"1997","journal-title":"Klinische Monatsblatter fur Augenheilkunde"},{"key":"10.1002\/14651858.CD009566.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0091-6749(03)80834-5","article-title":"An environmental study of ophthalmic epinastine in patients with allergic conjunctivitis","volume":"111","author":"Abelson","year":"2003","journal-title":"Journal Allergy Clinical Immunology"},{"issue":"8","key":"10.1002\/14651858.CD009566.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0149-2918(04)80065-1","article-title":"Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a randomized, double-masked environmental study","volume":"26","author":"Abelson","year":"2004","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD009566.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1034\/j.1600-0420.2000.078s230064.x","article-title":"A forced choice comfort study of olopatadine hydrochloride 0.1% versus ketotifen fumarate 0.05%","volume":"78","author":"Artal","year":"2000","journal-title":"Acta Ophthalmologica Scandinavica. Supplement"},{"issue":"5","key":"10.1002\/14651858.CD009566.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1755-3768.2008.01265.x","article-title":"Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial","volume":"87","author":"Borazan","year":"2009","journal-title":"Acta Ophthalmologica"},{"key":"10.1002\/14651858.CD009566.pub2-BIB0035|cit35","first-page":"114","article-title":"Seasonal allergic conjunctivitis: a pilot study of the clinical efficacy of azelastine eye drops in comparison with nedocromil","volume":"86","author":"Garay","year":"2001","journal-title":"Annals of Allergy, Asthma and Immunology"},{"issue":"12","key":"10.1002\/14651858.CD009566.pub2-BIB0036|cit36","first-page":"1501","article-title":"Clinical trial of disodium cromoglycate and AA-344 in allergic conjunctivitis","volume":"3","author":"Higuchi","year":"1979","journal-title":"Journal of Clinical Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD009566.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1600-0420.2006.00620.x","article-title":"Comparison of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and artificial tears in seasonal allergic conjunctivitis","volume":"84","author":"Kamis","year":"2006","journal-title":"Acta Ophthalmologica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD009566.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1398-9995.1994.tb00817.x","article-title":"A double-blind group comparative study of ophthalmic sodium cromoglycate, 2% four times daily and 4% twice daily, in the treatment of seasonal allergic conjunctivitis","volume":"49","author":"Leino","year":"1994","journal-title":"Allergy"},{"issue":"8","key":"10.1002\/14651858.CD009566.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1185\/030079904125004321","article-title":"Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preference","volume":"20","author":"Leonardi","year":"2004","journal-title":"Current Medical Research & Opinion"},{"issue":"5","key":"10.1002\/14651858.CD009566.pub2-BIB0040|cit40","first-page":"425","article-title":"Sodium cromoglycate in allergic conjunctivitis. Treatment experience","volume":"26","author":"Longo","year":"1979","journal-title":"Folia Allergologica et Immunologica Clinica"},{"issue":"8","key":"10.1002\/14651858.CD009566.pub2-BIB0041|cit41","first-page":"433","article-title":"Effectiveness and impact in the quality of life of Ketotifen ophthalmic solution. Results of Zeta study in patients with seasonal allergic conjunctivitis","volume":"78","author":"Merayo","year":"2003","journal-title":"Archivos de la Sociedad Espa\u00f1ola de Oftalmologia"},{"key":"10.1002\/14651858.CD009566.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1399-3038.1990.tb00016.x","article-title":"Levocabastine eyedrops in comparison with cromoglycate in the treatment of conjunctivitis in children with birch pollinosis","volume":"1","author":"M\u00f6ller","year":"1990","journal-title":"Pediatric Allergy and Immunology"},{"issue":"1","key":"10.1002\/14651858.CD009566.pub2-BIB0043|cit43","first-page":"21","article-title":"Long-term follow-up of allergic conjunctivitis in children: the outpatients' department experience (allergic conjunctivitis in children: management and care)","volume":"37","author":"Napoli","year":"2005","journal-title":"European Annals of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1002\/14651858.CD009566.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00019053-200119030-00004","article-title":"Cost effectiveness of emedastine versus levocabastine in the treatment of allergic conjunctivitis in 7 European countries","volume":"19","author":"Pinto","year":"2001","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1002\/14651858.CD009566.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/030006059902700603","article-title":"Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis. Riperex Study Group","volume":"27","author":"Scadding","year":"1999","journal-title":"Journal of International Medical Research"},{"issue":"6","key":"10.1002\/14651858.CD009566.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/BF02877768","article-title":"Perception and quality of life associated with the use of olopatadine 0.2% (Pataday) in patients with active allergic conjunctivitis","volume":"24","author":"Scoper","year":"2007","journal-title":"Advances in Therapy"},{"issue":"7","key":"10.1002\/14651858.CD009566.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0149-2918(08)80050-1","article-title":"Ocular comfort and drying effects of three topical antihistamine\/mast cell stabilizers in adults with allergic conjunctivitis: a randomized, double-masked crossover study","volume":"30","author":"Torkildsen","year":"2008","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD009566.pub2-BIB0048|cit48","unstructured":"Dharmistha P Sarala N Datti NP Comparative study of topical olopatadine hcl 0.1% with ketotifen fumarate 0.025% in treatment of allergic conjunctivitis Indian Journal of Pharmacology Conference: 46th Annual Conference of the Indian Pharmacological Society, IPSCON; 2013 Dec 16\u201318; Bangalore 2013"},{"key":"10.1002\/14651858.CD009566.pub2-BIB0049|cit49","unstructured":"Jia HL Liu CM Deng HW Han B Zhu XL Clinical study of Azelastine eye drops in children with allergic conjunctivitis International Eye Science 2012 780 1"},{"key":"10.1002\/14651858.CD009566.pub2-BIB0050|cit50","unstructured":"Scandashree K Patil M Udaykumar P Mendonca N Comparison of efficacy and tolerability of olopatadine hydrochloride 0.2% ophthalmic solution Od and sodium cromoglycate 2% ophthalmic solution qid in allergic conjunctivitis - A randomized, open label, prospective study Indian Journal of Pharmacology Conference: 46th Annual Conference of the Indian Pharmacological Society, IPSCON; 2013 Dec 16\u201318; Bangalore 2013"},{"key":"10.1002\/14651858.CD009566.pub2-BIB0051|cit51","first-page":"362","article-title":"Histamine in the eye","volume-title":"Immunology and Immunopathology of the Eye","author":"Abelson","year":"1979"},{"issue":"6","key":"10.1002\/14651858.CD009566.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1046\/j.1365-2222.2001.01148.x","article-title":"Management of seasonal allergic conjunctivitis (SAC): current therapeutic strategies","volume":"31","author":"Anderson","year":"2001","journal-title":"Clinical and Experimental Allergy"},{"issue":"9111","key":"10.1002\/14651858.CD009566.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(97)07302-9","article-title":"Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC","volume":"351","author":"Beasley","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009566.pub2-BIB0054|cit54","first-page":"23","article-title":"Allergic eye disease","volume-title":"ABC of Allergies","author":"Buckley","year":"1998"},{"issue":"2","key":"10.1002\/14651858.CD009566.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/1568010023344733","article-title":"Mechanisms of antihistamines and mast cell stabilizers in ocular allergic inflammation","volume":"1","author":"Cook","year":"2002","journal-title":"Current Drug Targets. Inflammation and Allergy"},{"issue":"6560","key":"10.1002\/14651858.CD009566.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1136\/bmj.293.6560.1477","article-title":"Eye disease at a community health centre","volume":"293","author":"Dart","year":"1986","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD009566.pub2-BIB0057|cit57","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"key":"10.1002\/14651858.CD009566.pub2-BIB0058|cit58","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009566.pub2-BIB0059|cit59","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16. Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009566.pub2-BIB0060|cit60","first-page":"1645","article-title":"Ocular allergy","volume-title":"Allergy and Allergic Disease","author":"Hingorani","year":"1997"},{"issue":"3","key":"10.1002\/14651858.CD009566.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/14728214.10.3.505","article-title":"Emerging drugs in ocular allergy","volume":"10","author":"Leonardi","year":"2005","journal-title":"Expert Opinion on Emerging Drugs"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009566.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2249.2008.03716.x","article-title":"Allergy and the eye","volume":"153","author":"Leonardi","year":"2008","journal-title":"Clinical and Experimental Immunology"},{"issue":"1","key":"10.1002\/14651858.CD009566.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaci.2004.10.042","article-title":"Allergic conjunctivitis: update on pathophysiology and prospects for future treatment","volume":"115","author":"Ono","year":"2005","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD009566.pub2-BIB0064|cit64","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"Suppl 9A","key":"10.1002\/14651858.CD009566.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9343(02)01436-5","article-title":"Comparative pharmacology of H1 antihistamines: clinical relevance","volume":"113","author":"Simons","year":"2002","journal-title":"American Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009566.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1399-3038.1997.tb00156.x","article-title":"Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC)","volume":"8","author":"Strachan","year":"1997","journal-title":"Pediatric Allergy and Immunology"},{"issue":"4","key":"10.1002\/14651858.CD009566.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.iio.0000212140.70051.33","article-title":"Recent advances in ocular therapeutics","volume":"46","author":"Whitcup","year":"2006","journal-title":"International Ophthalmology Clinics"},{"issue":"1","key":"10.1002\/14651858.CD009566.pub2-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009566","article-title":"Topical antihistamines for treating seasonal and perennial allergic conjunctivitis","author":"Mustafa","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009566.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T10:49:19Z","timestamp":1720694959000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009566.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,1]]},"references-count":68,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009566.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,1]]}}}